NDC 67877-0230-22
Mycophenolate mofetil 200 mg/mL POWDER, FOR SUSPENSION
Available — 2-Day Shipping
NDC
67877-0230-22
Generic Name
Mycophenolate mofetil
Brand Name
Mycophenolate mofetil
Strength
200 mg/mL
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Package Size
—
Labeler
Ascend Laboratories, LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies ( 14.1 )], heart [see Clinical Studies ( 14.2 )] or liver transplants [see Clinical Studies ( 14.3 )], in combination with other immunosuppressants. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Mycophenolate mofetil Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Mycophenolate mofetil NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 67877-0230-22 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).